FDA Import Refusal SCS-4882374-9/10003/1 — Boehringer Ingelheim

Boehringer Ingelheim — FEI 3009378855

The FDA refused shipment SCS-4882374-9/10003/1 from Boehringer Ingelheim (France) on October 27, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.